Trichy Daily

Bovine Respiratory Disease Treatment Market size is estimated to reach $1.3 billion by 2027 – IndustryARC

 Breaking News
  • No posts were found

Bovine Respiratory Disease Treatment Market size is estimated to reach $1.3 billion by 2027 – IndustryARC

September 20
03:09 2022
Bovine Respiratory Disease Treatment Market size is estimated to reach $1.3 billion by 2027 - IndustryARC
Market Research Reports, Business Consulting Services & Analytics
Bovine Respiratory Disease Treatment Market size is estimated to reach $1.3 billion by 2027, growing at a CAGR of 9.3% during the forecast period 2022-2027.

Bovine Respiratory Disease Treatment Market size is estimated to reach $1.3 billion by 2027, growing at a CAGR of 9.3% during the forecast period 2022-2027. Bovine respiratory disease (BRD) is the most typical and expensive ailment affecting beef cattle in the world. It is a complicated, bacterial infection that brings about pneumonia in calves which can be deadly. The infection is customarily a total of three co-reliant determinants: stress, an underlying viral infection, and a novel bacterial infection. Bovine respiratory disease (BRD) is one of the most typical indications for antimicrobial therapy in beef cattle production and research trials display that antibiotic therapy considerably enhances clinical outcomes for BRD.

Competitive Landscape:

The top 5 players in the Bovine Respiratory Disease Treatment  industry are –

1. Bayer Corporation

2. Boehringer Ingelheim GmbH

3. Bimeda Animal Health 

4. Elanco Animal Health

5. Vetoquinol S.A

 

Interested in knowing more relevant information? Click here:

 https://www.industryarc.com/pdfdownload.php?id=17344

 

Segmental Analysis:

1. The Bovine Respiratory Disease Treatment Market based on treatment type can be further segmented into Vaccines, Antibiotics, NSAIDs, Immunomodulators, and Others. The Vaccines segment held the largest market share in 2021. 

2. The Bovine Respiratory Disease Treatment Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America, and Rest of the World. North America (Bovine Respiratory Disease Treatment Market) held the largest share with 35% of the overall market in 2021.

3. The Bovine Respiratory Disease Treatment Market based on distribution channel can be further segmented into Veterinary Hospitals, Veterinary Clinics, Private Veterinary Pharmacies, and Veterinary Research Institutes.

 

Report Coverage

Report Attributes

Details

By Treatment Type

 

Vaccines, Antibiotics, NSAIDs, Immunomodulators, Others.

 

By Disease Type

 

Lower Respiratory Tract Infections, Upper Respiratory Tract Infections, Diphtheria.

 

By Distribution Channel

 

Veterinary Hospitals, Veterinary Clinics, Private Veterinary Pharmacies, Veterinary Research Institutes.

 

By Geography

North America, Europe, Asia-Pacific, South America and Rest of World

 

Get more detailed information about these segments in the report. Buy it here:

 https://www.industryarc.com/reports/request-quote?id=17344

 

Market Drivers and Challenges:

1. Surging Applications Of Cephalosporins Are Projected To Drive The Growth Of Bovine Respiratory Disease Treatment Market: Cephalosporin medications are efficient treatments for numerous typical cattle ailments. These beneficial medicines are efficient, readily accessible, cost-efficient, and possess short milk and meat withholding times. 

2. Proliferating Applications Of Combinations Of Antibiotics And Anti-Inflammatory Agents Are Expected To Boost The Demand For Bovine Respiratory Disease Treatment: The therapeutic approach to bovine respiratory disease (BRD) frequently includes a combination of an antibiotic with an anti-inflammatory agent. Investigations have been performed to assess the clinical impact of a novel combination product including tulathromycin and ketoprofen for the treatment of naturally happening BRD. 

3. Challenges Of Bovine Respiratory Disease (BRD) Are Hampering The Growth Of The Bovine Respiratory Disease Treatment Market: Bovine respiratory disease (BRD) is the most typical and expensive ailment of beef cattle in North America. Bovine respiratory diseases (BRD) and undifferentiated fevers are estimated to cost the North American cattle industry up to US$1 billion every year. In spite of comprehensive research, industry practices are frequently more informed by belief than by fact.

 

Why IndustryARC?

IndustryARC is one of the leading market research and consulting firms in the world. It produces over 500 unique market reports annually. Get detailed report on preferred market as per your specific requirements and our research experts would customize the report for you.

Email: [email protected]

USA: (+1) 614-588-8538,  (+1) 815-656-4596

 

Similar Reports:

A. Veterinary Vaccines Market

https://www.industryarc.com/Report/9591/veterinary-vaccines-market.html

B. Respiratory Infectious Disease Diagnostics Market

https://www.industryarc.com/Research/Respiratory-Infectious-Disease-Diagnostics-Market-Research-502411

Media Contact
Company Name: IndustryARC
Contact Person: Mr. Venkat Reddy
Email: Send Email
Phone: (+1) 970-236-3677
Address:Madhapur
City: Hyderabad
Country: India
Website: https://www.industryarc.com/Report/17344/bovine-respiratory-disease-treatment-market.html

Related Articles